In vivo glutamate neurotoxicity is associated with reductions in calcium/calmodulin-dependent protein kinase II immunoreactivity

Calcium/calmodulin‐dependent protein kinase II (CaM kinase) activity is inhibited in cultured hippocampal cells following direct application of glutamate. The goal of the present study was to determine if hippocampal regions that undergo delayed cell death following glutamate microinfusion would exh...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neuroscience research 1999-04, Vol.56 (1), p.36-43
Hauptverfasser: Babcock, Alex M., Liu, Hui, Paden, Charles M., Churn, Severn B., Pittman, Andrew J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 43
container_issue 1
container_start_page 36
container_title Journal of neuroscience research
container_volume 56
creator Babcock, Alex M.
Liu, Hui
Paden, Charles M.
Churn, Severn B.
Pittman, Andrew J.
description Calcium/calmodulin‐dependent protein kinase II (CaM kinase) activity is inhibited in cultured hippocampal cells following direct application of glutamate. The goal of the present study was to determine if hippocampal regions that undergo delayed cell death following glutamate microinfusion would exhibit changes in CaM kinase immunoreactivity. Gerbils received bilateral intra‐hippocampal infusions of L‐glutamate (34 μg/μl), or control treatments of D‐glutamate or saline. Animals were sacrificed at 12 or 24 hr to assess cell loss and determine changes in CaM kinase‐like immunoreactivity. Hippocampi of gerbils euthanized 12 hr following L‐glutamate, or 24 hr following D‐glutamate, did not exhibit cell death in the hippocampal CA1 region. Animals injected with L‐glutamate and sacrificed 24 hr after infusion had extensive cell damage that was restricted to the hippocampal CA1 region. CaM kinase‐like immunoreactivity was absent in the hippocampal CA1 region of all L‐glutamate treated animals sacrificed at 12 hr. In these same sections, CaM kinase immunoreactivity was evident in the subiculum, CA2 and CA3 regions. Reduction in CaM kinase immunoreactivity following L‐glutamate were also observed using Western analysis. The results confirm and extend the findings of earlier cell culture studies by demonstrating a reduction in CaM kinase immunoreactivity that occurred prior to cell death. J. Neurosci. Res. 56:36–43, 1999.  © 1999 Wiley‐Liss, Inc.
doi_str_mv 10.1002/(SICI)1097-4547(19990401)56:1<36::AID-JNR5>3.0.CO;2-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17236598</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17236598</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4325-8b1b629a460731ff833da90d33c79e5de3098edc6b19ea030253bb7519bc97783</originalsourceid><addsrcrecordid>eNqFkU9v1DAQxSMEoqXwFZBPqD1ka2die70UpCrAEqh2JSjqceQ4XjDNnyVOtt0bHx2HXQoSSJxGo5n5vad5UfSC0QmjNDk9_phn-QmjSsYpT-UxU0rRlLITLmbsDMRsdp6_it8tPvCXMKGTbPk8idN70eHdxf3okIKgcbhJDqJH3n-llCrF4WF0wGjCIJVwGH3PG7Jxm5Z8roZe17q3pLFD1_btrTOu3xLnifa-NS6MSnLj-i-ks-Vgetc2nriGGF0ZN9SnodZtOVSuiUu7tk1pm56sA8mGpWvXaG9JnhNX10PTdlYHwiYIPI4erHTl7ZN9PYo-vXl9mb2NL5bzPDu_iE0KCY-nBStEonQqqAS2Wk0BSq1oCWCksry0QNXUlkYUTFlNgSYcikJypgqjpJzCUfRsxw2Wvg3W91g7b2xV6ca2g0cmExBcjYt7A6Zrve_sCtedq3W3RUZxjAZxjAbHR-P4aPwVDXKBDEEghmhwjAYBKWZLTDAN3Kd7A0NR2_IP6i6L38I3rrLbv1T_J_oPzZ994MY7rvO9vb3j6u4ahQTJ8Woxx_dXl4s5iCwY_QHiMLsh</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17236598</pqid></control><display><type>article</type><title>In vivo glutamate neurotoxicity is associated with reductions in calcium/calmodulin-dependent protein kinase II immunoreactivity</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Babcock, Alex M. ; Liu, Hui ; Paden, Charles M. ; Churn, Severn B. ; Pittman, Andrew J.</creator><creatorcontrib>Babcock, Alex M. ; Liu, Hui ; Paden, Charles M. ; Churn, Severn B. ; Pittman, Andrew J.</creatorcontrib><description>Calcium/calmodulin‐dependent protein kinase II (CaM kinase) activity is inhibited in cultured hippocampal cells following direct application of glutamate. The goal of the present study was to determine if hippocampal regions that undergo delayed cell death following glutamate microinfusion would exhibit changes in CaM kinase immunoreactivity. Gerbils received bilateral intra‐hippocampal infusions of L‐glutamate (34 μg/μl), or control treatments of D‐glutamate or saline. Animals were sacrificed at 12 or 24 hr to assess cell loss and determine changes in CaM kinase‐like immunoreactivity. Hippocampi of gerbils euthanized 12 hr following L‐glutamate, or 24 hr following D‐glutamate, did not exhibit cell death in the hippocampal CA1 region. Animals injected with L‐glutamate and sacrificed 24 hr after infusion had extensive cell damage that was restricted to the hippocampal CA1 region. CaM kinase‐like immunoreactivity was absent in the hippocampal CA1 region of all L‐glutamate treated animals sacrificed at 12 hr. In these same sections, CaM kinase immunoreactivity was evident in the subiculum, CA2 and CA3 regions. Reduction in CaM kinase immunoreactivity following L‐glutamate were also observed using Western analysis. The results confirm and extend the findings of earlier cell culture studies by demonstrating a reduction in CaM kinase immunoreactivity that occurred prior to cell death. J. Neurosci. Res. 56:36–43, 1999.  © 1999 Wiley‐Liss, Inc.</description><identifier>ISSN: 0360-4012</identifier><identifier>EISSN: 1097-4547</identifier><identifier>DOI: 10.1002/(SICI)1097-4547(19990401)56:1&lt;36::AID-JNR5&gt;3.0.CO;2-4</identifier><identifier>PMID: 10213473</identifier><language>eng</language><publisher>New York: John Wiley &amp; Sons, Inc</publisher><subject>Animals ; Calcium-Calmodulin-Dependent Protein Kinase Type 2 ; Calcium-Calmodulin-Dependent Protein Kinases - metabolism ; Cell Death ; Cell Survival - drug effects ; cerebral ischemia ; Functional Laterality ; Gerbillinae ; Glutamic Acid - administration &amp; dosage ; Glutamic Acid - toxicity ; hippocampus ; Hippocampus - drug effects ; Hippocampus - enzymology ; Hippocampus - pathology ; immunocytochemistry ; Infusions, Parenteral ; Neurons - drug effects ; Neurons - enzymology ; Neurons - pathology ; Neurotoxins - administration &amp; dosage ; Neurotoxins - toxicity ; pyramidal cells</subject><ispartof>Journal of neuroscience research, 1999-04, Vol.56 (1), p.36-43</ispartof><rights>Copyright © 1999 Wiley‐Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4325-8b1b629a460731ff833da90d33c79e5de3098edc6b19ea030253bb7519bc97783</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F%28SICI%291097-4547%2819990401%2956%3A1%3C36%3A%3AAID-JNR5%3E3.0.CO%3B2-4$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F%28SICI%291097-4547%2819990401%2956%3A1%3C36%3A%3AAID-JNR5%3E3.0.CO%3B2-4$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10213473$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Babcock, Alex M.</creatorcontrib><creatorcontrib>Liu, Hui</creatorcontrib><creatorcontrib>Paden, Charles M.</creatorcontrib><creatorcontrib>Churn, Severn B.</creatorcontrib><creatorcontrib>Pittman, Andrew J.</creatorcontrib><title>In vivo glutamate neurotoxicity is associated with reductions in calcium/calmodulin-dependent protein kinase II immunoreactivity</title><title>Journal of neuroscience research</title><addtitle>J. Neurosci. Res</addtitle><description>Calcium/calmodulin‐dependent protein kinase II (CaM kinase) activity is inhibited in cultured hippocampal cells following direct application of glutamate. The goal of the present study was to determine if hippocampal regions that undergo delayed cell death following glutamate microinfusion would exhibit changes in CaM kinase immunoreactivity. Gerbils received bilateral intra‐hippocampal infusions of L‐glutamate (34 μg/μl), or control treatments of D‐glutamate or saline. Animals were sacrificed at 12 or 24 hr to assess cell loss and determine changes in CaM kinase‐like immunoreactivity. Hippocampi of gerbils euthanized 12 hr following L‐glutamate, or 24 hr following D‐glutamate, did not exhibit cell death in the hippocampal CA1 region. Animals injected with L‐glutamate and sacrificed 24 hr after infusion had extensive cell damage that was restricted to the hippocampal CA1 region. CaM kinase‐like immunoreactivity was absent in the hippocampal CA1 region of all L‐glutamate treated animals sacrificed at 12 hr. In these same sections, CaM kinase immunoreactivity was evident in the subiculum, CA2 and CA3 regions. Reduction in CaM kinase immunoreactivity following L‐glutamate were also observed using Western analysis. The results confirm and extend the findings of earlier cell culture studies by demonstrating a reduction in CaM kinase immunoreactivity that occurred prior to cell death. J. Neurosci. Res. 56:36–43, 1999.  © 1999 Wiley‐Liss, Inc.</description><subject>Animals</subject><subject>Calcium-Calmodulin-Dependent Protein Kinase Type 2</subject><subject>Calcium-Calmodulin-Dependent Protein Kinases - metabolism</subject><subject>Cell Death</subject><subject>Cell Survival - drug effects</subject><subject>cerebral ischemia</subject><subject>Functional Laterality</subject><subject>Gerbillinae</subject><subject>Glutamic Acid - administration &amp; dosage</subject><subject>Glutamic Acid - toxicity</subject><subject>hippocampus</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - enzymology</subject><subject>Hippocampus - pathology</subject><subject>immunocytochemistry</subject><subject>Infusions, Parenteral</subject><subject>Neurons - drug effects</subject><subject>Neurons - enzymology</subject><subject>Neurons - pathology</subject><subject>Neurotoxins - administration &amp; dosage</subject><subject>Neurotoxins - toxicity</subject><subject>pyramidal cells</subject><issn>0360-4012</issn><issn>1097-4547</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU9v1DAQxSMEoqXwFZBPqD1ka2die70UpCrAEqh2JSjqceQ4XjDNnyVOtt0bHx2HXQoSSJxGo5n5vad5UfSC0QmjNDk9_phn-QmjSsYpT-UxU0rRlLITLmbsDMRsdp6_it8tPvCXMKGTbPk8idN70eHdxf3okIKgcbhJDqJH3n-llCrF4WF0wGjCIJVwGH3PG7Jxm5Z8roZe17q3pLFD1_btrTOu3xLnifa-NS6MSnLj-i-ks-Vgetc2nriGGF0ZN9SnodZtOVSuiUu7tk1pm56sA8mGpWvXaG9JnhNX10PTdlYHwiYIPI4erHTl7ZN9PYo-vXl9mb2NL5bzPDu_iE0KCY-nBStEonQqqAS2Wk0BSq1oCWCksry0QNXUlkYUTFlNgSYcikJypgqjpJzCUfRsxw2Wvg3W91g7b2xV6ca2g0cmExBcjYt7A6Zrve_sCtedq3W3RUZxjAZxjAbHR-P4aPwVDXKBDEEghmhwjAYBKWZLTDAN3Kd7A0NR2_IP6i6L38I3rrLbv1T_J_oPzZ994MY7rvO9vb3j6u4ahQTJ8Woxx_dXl4s5iCwY_QHiMLsh</recordid><startdate>19990401</startdate><enddate>19990401</enddate><creator>Babcock, Alex M.</creator><creator>Liu, Hui</creator><creator>Paden, Charles M.</creator><creator>Churn, Severn B.</creator><creator>Pittman, Andrew J.</creator><general>John Wiley &amp; Sons, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope></search><sort><creationdate>19990401</creationdate><title>In vivo glutamate neurotoxicity is associated with reductions in calcium/calmodulin-dependent protein kinase II immunoreactivity</title><author>Babcock, Alex M. ; Liu, Hui ; Paden, Charles M. ; Churn, Severn B. ; Pittman, Andrew J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4325-8b1b629a460731ff833da90d33c79e5de3098edc6b19ea030253bb7519bc97783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Animals</topic><topic>Calcium-Calmodulin-Dependent Protein Kinase Type 2</topic><topic>Calcium-Calmodulin-Dependent Protein Kinases - metabolism</topic><topic>Cell Death</topic><topic>Cell Survival - drug effects</topic><topic>cerebral ischemia</topic><topic>Functional Laterality</topic><topic>Gerbillinae</topic><topic>Glutamic Acid - administration &amp; dosage</topic><topic>Glutamic Acid - toxicity</topic><topic>hippocampus</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - enzymology</topic><topic>Hippocampus - pathology</topic><topic>immunocytochemistry</topic><topic>Infusions, Parenteral</topic><topic>Neurons - drug effects</topic><topic>Neurons - enzymology</topic><topic>Neurons - pathology</topic><topic>Neurotoxins - administration &amp; dosage</topic><topic>Neurotoxins - toxicity</topic><topic>pyramidal cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Babcock, Alex M.</creatorcontrib><creatorcontrib>Liu, Hui</creatorcontrib><creatorcontrib>Paden, Charles M.</creatorcontrib><creatorcontrib>Churn, Severn B.</creatorcontrib><creatorcontrib>Pittman, Andrew J.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><jtitle>Journal of neuroscience research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Babcock, Alex M.</au><au>Liu, Hui</au><au>Paden, Charles M.</au><au>Churn, Severn B.</au><au>Pittman, Andrew J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vivo glutamate neurotoxicity is associated with reductions in calcium/calmodulin-dependent protein kinase II immunoreactivity</atitle><jtitle>Journal of neuroscience research</jtitle><addtitle>J. Neurosci. Res</addtitle><date>1999-04-01</date><risdate>1999</risdate><volume>56</volume><issue>1</issue><spage>36</spage><epage>43</epage><pages>36-43</pages><issn>0360-4012</issn><eissn>1097-4547</eissn><abstract>Calcium/calmodulin‐dependent protein kinase II (CaM kinase) activity is inhibited in cultured hippocampal cells following direct application of glutamate. The goal of the present study was to determine if hippocampal regions that undergo delayed cell death following glutamate microinfusion would exhibit changes in CaM kinase immunoreactivity. Gerbils received bilateral intra‐hippocampal infusions of L‐glutamate (34 μg/μl), or control treatments of D‐glutamate or saline. Animals were sacrificed at 12 or 24 hr to assess cell loss and determine changes in CaM kinase‐like immunoreactivity. Hippocampi of gerbils euthanized 12 hr following L‐glutamate, or 24 hr following D‐glutamate, did not exhibit cell death in the hippocampal CA1 region. Animals injected with L‐glutamate and sacrificed 24 hr after infusion had extensive cell damage that was restricted to the hippocampal CA1 region. CaM kinase‐like immunoreactivity was absent in the hippocampal CA1 region of all L‐glutamate treated animals sacrificed at 12 hr. In these same sections, CaM kinase immunoreactivity was evident in the subiculum, CA2 and CA3 regions. Reduction in CaM kinase immunoreactivity following L‐glutamate were also observed using Western analysis. The results confirm and extend the findings of earlier cell culture studies by demonstrating a reduction in CaM kinase immunoreactivity that occurred prior to cell death. J. Neurosci. Res. 56:36–43, 1999.  © 1999 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>10213473</pmid><doi>10.1002/(SICI)1097-4547(19990401)56:1&lt;36::AID-JNR5&gt;3.0.CO;2-4</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0360-4012
ispartof Journal of neuroscience research, 1999-04, Vol.56 (1), p.36-43
issn 0360-4012
1097-4547
language eng
recordid cdi_proquest_miscellaneous_17236598
source MEDLINE; Wiley Online Library All Journals
subjects Animals
Calcium-Calmodulin-Dependent Protein Kinase Type 2
Calcium-Calmodulin-Dependent Protein Kinases - metabolism
Cell Death
Cell Survival - drug effects
cerebral ischemia
Functional Laterality
Gerbillinae
Glutamic Acid - administration & dosage
Glutamic Acid - toxicity
hippocampus
Hippocampus - drug effects
Hippocampus - enzymology
Hippocampus - pathology
immunocytochemistry
Infusions, Parenteral
Neurons - drug effects
Neurons - enzymology
Neurons - pathology
Neurotoxins - administration & dosage
Neurotoxins - toxicity
pyramidal cells
title In vivo glutamate neurotoxicity is associated with reductions in calcium/calmodulin-dependent protein kinase II immunoreactivity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T00%3A11%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vivo%20glutamate%20neurotoxicity%20is%20associated%20with%20reductions%20in%20calcium/calmodulin-dependent%20protein%20kinase%20II%20immunoreactivity&rft.jtitle=Journal%20of%20neuroscience%20research&rft.au=Babcock,%20Alex%20M.&rft.date=1999-04-01&rft.volume=56&rft.issue=1&rft.spage=36&rft.epage=43&rft.pages=36-43&rft.issn=0360-4012&rft.eissn=1097-4547&rft_id=info:doi/10.1002/(SICI)1097-4547(19990401)56:1%3C36::AID-JNR5%3E3.0.CO;2-4&rft_dat=%3Cproquest_cross%3E17236598%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17236598&rft_id=info:pmid/10213473&rfr_iscdi=true